[{"uuid": "334d53a3-295b-311b-9cc1-a8cb788d3322", "title": "Why Guardant Health, Inc. (GH) Is Among the Best Booming Stocks to Invest in Now?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-guardant-health-inc-gh-212700771.html", "providerPublishTime": 1738531620, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qPSqdNpSDK2UXRwU6g0kyw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2a5225bbb1b6e607d0c46f4a4303fa02", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/uduqItgRGODXRWg5t7JMPg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2a5225bbb1b6e607d0c46f4a4303fa02", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "808bf65e-7390-3b62-89b7-4d46610d72a8", "title": "Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/guardant-health-report-fourth-quarter-210500186.html", "providerPublishTime": 1738271100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/MpGMNG0hCoU7IPiarJNqiA--~B/aD02MTk7dz0xODA2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/33521b923f9314036b94ec701ba6d9fd", "width": 1806, "height": 619, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/cTXGn.HOCtc.wbRAaF_1cw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/33521b923f9314036b94ec701ba6d9fd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "1f635859-22be-39e7-8ca0-bb8ecd7fdb4a", "title": "Guardant Health Selected by Abu Dhabi Health Department to Launch Colorectal Cancer Screening Program", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/guardant-health-selected-abu-dhabi-154413341.html", "providerPublishTime": 1738251853, "type": "STORY", "relatedTickers": ["GH"]}, {"uuid": "b6e6c544-3537-384e-ad33-26e2ded91ba1", "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-140010515.html", "providerPublishTime": 1738245610, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/9tpS8u8rAmiEoUItmUZeOA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pDKsOs.OZIPdDtC_zqOnWw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH", "CELG-RT"]}, {"uuid": "60e49304-cfb0-3638-94f7-12edb117c319", "title": "Guardant Health\u2019s Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/guardant-health-shield-test-selected-130500127.html", "providerPublishTime": 1738242300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ImBlThJ2eeTKw5fJ0eIhfQ--~B/aD02MTk7dz0xODA2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/6c70417f1f451788a92207f3695bb9c7", "width": 1806, "height": 619, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/8CqU7zPNABas98J7RqNVaw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/6c70417f1f451788a92207f3695bb9c7", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "89284417-6937-39ad-8cd1-f9e9e477457d", "title": "Why Guardant Health (GH) Is Skyrocketing Now", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-guardant-health-gh-skyrocketing-082240697.html", "providerPublishTime": 1737879760, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qPSqdNpSDK2UXRwU6g0kyw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2a5225bbb1b6e607d0c46f4a4303fa02", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/uduqItgRGODXRWg5t7JMPg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2a5225bbb1b6e607d0c46f4a4303fa02", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "9388c976-4185-3c30-9073-78c90236b28a", "title": "Barclays Initiates Guardant Health at Overweight", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/barclays-initiates-guardant-health-overweight-134338168.html", "providerPublishTime": 1737639818, "type": "STORY", "relatedTickers": ["GH"]}, {"uuid": "90e6bae5-5386-34aa-990b-729ab767b3d9", "title": "Guardant Health to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/guardant-health-present-data-asco-130500719.html", "providerPublishTime": 1737637500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sIUcVLXRt3KJ75w2cqiGIA--~B/aD02MTk7dz0xODA2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e0232a03cb581c6ade84a68b792ae17c", "width": 1806, "height": 619, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/xBj5_PiYFEDDJ3KG.KZ8ng--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e0232a03cb581c6ade84a68b792ae17c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "8b6e8af3-80a2-3eac-8880-89866dd4394c", "title": "Why Guardant Health, Inc. (GH) Soared At The Start Of The Trading Week", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-guardant-health-inc-gh-170407034.html", "providerPublishTime": 1737565447, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qPSqdNpSDK2UXRwU6g0kyw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2a5225bbb1b6e607d0c46f4a4303fa02", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/uduqItgRGODXRWg5t7JMPg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2a5225bbb1b6e607d0c46f4a4303fa02", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "a4ab74fc-9616-3a24-83be-3954e8fcb4ba", "title": "Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/a4ab74fc-9616-3a24-83be-3954e8fcb4ba/why-top-4%25-guardant-health.html", "providerPublishTime": 1737493416, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pkMoLO.pyfSp54cgQiV6MQ--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/7cf647cbaae0a9ebd82db6130cd3aff5", "width": 945, "height": 533, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/_it32F4gjkE6wd8sJu8w4w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/7cf647cbaae0a9ebd82db6130cd3aff5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH", "EXAS", "NTRA"]}, {"uuid": "746a7480-46e4-3a6b-8100-c18709a25f09", "title": "Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/guardant-health-gains-medicare-coverage-191513060.html", "providerPublishTime": 1737486913, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.IfASQQm9ZgJx6ZQLFjoZg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/042477fc36e821f1c36201313266f8bd", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/E06nqflNQJIHwQUrgpwsLQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/042477fc36e821f1c36201313266f8bd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "10524a35-39f0-3bec-acd4-1103a711e34f", "title": "Guardant Health Gets Medicare Coverage for Guardant Reveal in CRC Surveillance Testing", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/guardant-health-gets-medicare-coverage-152603502.html", "providerPublishTime": 1737473163, "type": "STORY", "relatedTickers": ["GH"]}, {"uuid": "76c3fa9f-2a8f-3c4a-a968-857a581bb368", "title": "Guardant Health Receives Medicare Coverage for Guardant Reveal\u2122 on Smart Liquid Biopsy\u2122 Platform for Surveillance Testing in Colorectal Cancer Patients", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/guardant-health-receives-medicare-coverage-130500233.html", "providerPublishTime": 1737464700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KCPdNMqpp6abrwVo9kj0Bg--~B/aD02MTk7dz0xODA2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9a2b08acc3e63569a04ac539ec73e146", "width": 1806, "height": 619, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/qIil4fFnrMhsjbLbLGIT7A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9a2b08acc3e63569a04ac539ec73e146", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "826682da-dbf7-331f-9151-09bbfea0a049", "title": "Guardant Health, Inc. (GH) Partners with ConcertAI to Launch Advanced Real-World Data Solution for Enhanced Cancer Treatment and Clinical Trials", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/guardant-health-inc-gh-partners-170737548.html", "providerPublishTime": 1737392857, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qPSqdNpSDK2UXRwU6g0kyw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2a5225bbb1b6e607d0c46f4a4303fa02", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/uduqItgRGODXRWg5t7JMPg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2a5225bbb1b6e607d0c46f4a4303fa02", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "3e095b46-f3fe-38cf-b64c-5c898e455f2a", "title": "Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/3e095b46-f3fe-38cf-b64c-5c898e455f2a/exact-sciences-stock-drops.html", "providerPublishTime": 1737061513, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sOnQOK4D2pilBYgsDhm_KA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/2ad36331caf8055618f5bbcee86f6c9a", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WuTJqwcy7HTBDGr1AacPEg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/2ad36331caf8055618f5bbcee86f6c9a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EXAS", "NTRA", "GH"]}, {"uuid": "8d2e2fc3-da7e-39fb-9856-b2a58d9762af", "title": "Guardant Health, ConcertAI Working Together on Cancer Treatments", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/guardant-health-concertai-working-together-151443956.html", "providerPublishTime": 1737040483, "type": "STORY", "relatedTickers": ["GH"]}, {"uuid": "f96ef6ec-4f95-38c2-b69c-b69e0c406fcd", "title": "Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/guardant-health-concertai-collaborate-form-130500070.html", "providerPublishTime": 1737032700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_wFlMFwJhr0iwT6.cCJM1g--~B/aD02MTk7dz0xODA2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/dfc6511291dc55dcf92dc3930af1f603", "width": 1806, "height": 619, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/tRdL4X4zT2x9IfOq4vzgqw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/dfc6511291dc55dcf92dc3930af1f603", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "6468f8d9-35ca-3411-8ac6-5bfc18dfd6f5", "title": "JP Morgan 2025: Guardant reports $737m in preliminary full-year revenue", "publisher": "Medical Device Network", "link": "https://finance.yahoo.com/m/6468f8d9-35ca-3411-8ac6-5bfc18dfd6f5/jp-morgan-2025%3A-guardant.html", "providerPublishTime": 1736859581, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/80l6iFtcqbQDBN4o8c.FWA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/fec4221c07434809b6a32a57a15b7e7f", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/.jvWBzgFI5nqKKjjlFqZOg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/fec4221c07434809b6a32a57a15b7e7f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "a781b991-4e6b-3e9e-8cfe-8ee903618f13", "title": "Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/guardant-health-announces-preliminary-fourth-120000065.html", "providerPublishTime": 1736769600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/YIz877YIVmS2zABKeLp7Nw--~B/aD02MTk7dz0xODA2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/ccc4e388a25e73b031f0e1194cd75c9d", "width": 1806, "height": 619, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1FlHGpydmZXuAUIv0MNuwg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/ccc4e388a25e73b031f0e1194cd75c9d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GH"]}, {"uuid": "d3f3d9f5-8d48-3e84-b79c-c1b7649c5da7", "title": "Guardant Health Holds 'Underappreciated' Catalyst Path, UBS Says", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/guardant-health-holds-apos-underappreciated-201253364.html", "providerPublishTime": 1736539973, "type": "STORY", "relatedTickers": ["GH"]}]